Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Gabapentin Market Research Report 2011-2023

  • HEY1469069
  • 85 Pages
  • August 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
Summary

Gabapentin is an anti-epileptic medication, also called an anticonvulsant. It affects chemicals and nerves in the body that are involved in the cause of seizures and some types of pain.

The global Gabapentin market will reach Volume Million USD in 2017 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Tablet

Capsule

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Pfizer

GSK

Sailike

Jiangsu Enhua

Jiangsu Hengrui

Novartis

Actavis

Glenmark

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Nerve Pain

Restless Legs Syndrome

Seizures

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

1.1.2 Specifications

1.2 Market Segment

1.2.1 by Type

1.2.1.1 Tablet

1.2.1.2 Capsule

1.2.2 by Application

1.2.2.1 Nerve Pain

1.2.2.2 Restless Legs Syndrome

1.2.2.3 Seizures

1.2.3 by Regions

2 Industry Chain

2.1 Industry Chain Structure

2.2 Upstream

2.3 Market

2.3.1 SWOT

2.3.2 Dynamics

3 Environmental Analysis

3.1 Policy

3.2 Economic

3.3 Technology

3.4 Market Entry

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Tablet Market, 2011-2016

4.1.2 Capsule Market, 2011-2016

4.2 Market Forecast

4.2.1 Tablet Market Forecast, 2017-2022

4.2.2 Capsule Market Forecast, 2017-2022

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Nerve Pain Market, 2011-2016

5.1.2 Restless Legs Syndrome Market, 2011-2016

5.1.3 Seizures Market, 2011-2016

5.2 Market Forecast

5.2.1 Nerve Pain Market Forecast, 2017-2022

5.2.2 Restless Legs Syndrome Market Forecast, 2017-2022

5.2.3 Seizures Market Forecast, 2017-2022

6 Market Segmentation by Region

6.1 Market Size

6.1.1 Asia-Pacific

6.1.1.1 Asia-Pacific Market, 2011-2016

6.1.1.2 Asia-Pacific Market by Type

6.1.1.3 Asia-Pacific Market by Application

6.1.2 North America

6.1.2.1 North America Market, 2011-2016

6.1.2.2 North America Market by Type

6.1.2.3 North America Market by Application

6.1.3 Europe

6.1.3.1 Europe Market, 2011-2016

6.1.3.2 Europe Market by Type

6.1.3.3 Europe Market by Application

6.1.4 South America

6.1.4.1 South America Market, 2011-2016

6.1.4.2 South America Market by Type

6.1.4.3 South America Market by Application

6.1.5 Middle East & Africa

6.1.5.1 Middle East & Africa Market, 2011-2016

6.1.5.2 Middle East & Africa Market by Type

6.1.5.3 Middle East & Africa Market by Application

6.2 Market Forecast

6.2.1 Asia-Pacific Market Forecast, 2017-2022

6.2.2 North America Market Forecast, 2017-2022

6.2.3 Europe Market Forecast, 2017-2022

6.2.4 South America Market Forecast, 2017-2022

6.2.5 Middle East & Africa Market Forecast, 2017-2022

7 Market Competitive

7.1 Global Market by Vendors

7.2 Market Concentration

7.3 Price & Factors

7.4 Marketing Channel

8 Major Vendors

8.1 Pfizer

8.1.2 Profile

8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.2 GSK

8.2.1 Profile

8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.3 Sailike

8.3.1 Profile

8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.4 Jiangsu Enhua

8.4.1 Profile

8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.5 Jiangsu Hengrui

8.5.1 Profile

8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.6 Novartis

8.6.1 Profile

8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.7 Actavis

8.7.1 Profile

8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)

8.8 Glenmark

8.8.1 Profile

8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)

9 Conclusion


List Of Tables
Table Product Specifications of Gabapentin

Table Products Segment of Gabapentin

Table Tablet Overview

Table Capsule Overview

Table Global Gabapentin Market by Type, 2011-2022 (USD Million)

Table Application Segment of Gabapentin

Table Nerve Pain Overview

Table Restless Legs Syndrome Overview

Table Seizures Overview

Table Global Gabapentin Market by Application, 2011-2022 (USD Million)

Table Global Gabapentin Market by Region, 2011-2022 (USD Million)

Table Cost of Gabapentin

Table Market Dynamics

Table Policy of Gabapentin

Table GDP of Major Countries

Table Tablet CAGR by Revenue and Volume, 2011-2016

Table Capsule CAGR by Revenue and Volume, 2011-2016

Table Tablet CAGR by Revenue and Volume, 2012-2022

Table Capsule CAGR by Revenue and Volume, 2012-2022

Table Nerve Pain CAGR by Revenue and Volume, 2011-2016

Table Restless Legs Syndrome CAGR by Revenue and Volume, 2011-2016

Table Seizures CAGR by Revenue and Volume, 2011-2016


Lisst Of Figures
Figure Gabapentin Picture

Figure Industry Chain Structure of Gabapentin

Figure SWOT of Gabapentin

Figure Tablet Market Size and Growth, 2011-2016 (USD Million)

Figure Tablet Market Size and Growth, 2011-2016 (in Volume)

Figure Capsule Market Size and Growth, 2011-2016 (USD Million)

Figure Capsule Market Size and Growth, 2011-2016 (in Volume)

Figure Tablet Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Tablet Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Capsule Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Capsule Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Nerve Pain Market Size and Growth, 2011-2016 (USD Million)

Figure Nerve Pain Market Size and Growth, 2011-2016 (in Volume)

Figure Restless Legs Syndrome Market Size and Growth, 2011-2016 (USD Million)

Figure Restless Legs Syndrome Market Size and Growth, 2011-2016 (in Volume)

Figure Seizures Market Size and Growth, 2011-2016 (USD Million)

Figure Seizures Market Size and Growth, 2011-2016 (in Volume)

Figure Nerve Pain Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Nerve Pain Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Restless Legs Syndrome Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Restless Legs Syndrome Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Seizures Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Seizures Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)

Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)

Figure Asia-Pacific Market Size by Type

Figure Asia-Pacific Market Share by Type

Figure Asia-Pacific Market Size by Application

Figure Asia-Pacific Market Share by Application

Figure North America Market Size and Growth, 2011-2016 (USD Million)

Figure North America Market Size and Growth, 2011-2016 (in Volume)

Figure North America Market Size by Type

Figure North America Market Share by Type

Figure North America Market Size by Application

Figure North America Market Share by Application

Figure Europe Market Size and Growth, 2011-2016 (USD Million)

Figure Europe Market Size and Growth, 2011-2016 (in Volume)

Figure Europe Market Size by Type

Figure Europe Market Share by Type

Figure Europe Market Size by Application

Figure Europe Market Share by Application

Figure South America Market Size and Growth, 2011-2016 (USD Million)

Figure South America Market Size and Growth, 2011-2016 (in Volume)

Figure South America Market Size by Type

Figure South America Market Share by Type

Figure South America Market Size by Application

Figure South America Market Share by Application

Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)

Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)

Figure Middle East & Africa Market Size by Type

Figure Middle East & Africa Market Share by Type

Figure Middle East & Africa Market Size by Application

Figure Middle East & Africa Market Share by Application

Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)

Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)

Figure Gabapentin Market Concentration by Region

Figure Marketing Channels Overview

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390